Massive withdrawal symptoms and affective vulnerability are associated with variants of the CHRNA4 gene in a subgroup of smokers

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Lazary, Judit ^a   Dome, Peter ^a,b   Csala, Iren ^a   Kovacs, Gabor ^c   Faludi, Gabor ^a   Kaunisto, Mari ^d,e   Dome, Balazs ^c,f,g  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NATIONAL INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Hungary)

^c NATIONAL KORANYI INSTITUTE OF PULMONOLOGY   (Hungary)

^d UNIVERSITY OF HELSINKI   (Finland)

^e FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^f NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^g MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; NICOTINIC RECEPTOR ALPHA4;

ADULT; ARTICLE; CHRNA4 GENE; CLUSTER ANALYSIS; COHORT ANALYSIS; EXHALATION; FAGERSTROM TEST FOR NICOTINE DEPENDENCE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC IDENTIFICATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HELP SEEKING BEHAVIOR; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MINNESOTA NICOTINE WITHDRAWAL SCALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING CESSATION; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME; ZUNG SELF RATING DEPRESSION SCALE;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NICOTINE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, NICOTINIC; SELF REPORT; SMOKING; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84900454192     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087141     Document Type: Article

References (33)

1. Mokdad AH, Marks JS, Stroup DF, Gerberding JL (2004) Actual causes of death in the United States, 2000. Jama 291: 1238-1245. (Pubitemid 38541668)
2. Frieden TR, Bloomberg MR (2007) How to prevent 100 million deaths from tobacco. Lancet 369: 1758-1761. (Pubitemid 46755392)
3. Lukas RJ, Changeux JP, Le Novere N, Albuquerque EX, Balfour DJ, et al. (1999) International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev 51: 397-401. (Pubitemid 29269984)
4. Breitling LP, Dahmen N, Mittelstrass K, Rujescu D, Gallinat J, et al. (2009) Association of nicotinic acetylcholine receptor subunit alpha 4 polymorphisms with nicotine dependence in 5500 Germans. Pharmacogenomics J 9: 219-224.
5. Feng Y, Niu T, Xing H, Xu X, Chen C, et al. (2004) A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men. Am J Hum Genet 75: 112-121. (Pubitemid 38801907)
6. Etter JF, Hoda JC, Perroud N, Munafo M, Buresi C, et al. (2009) Association of genes coding for the alpha-4, alpha-5, beta-2 and beta-3 subunits of nicotinic receptors with cigarette smoking and nicotine dependence. Addict Behav 34: 772-775.
7. Spruell T, Colavita G, Donegan T, Egawhary M, Hurley M, et al. (2012) Association between nicotinic acetylcholine receptor single nucleotide polymorphisms and smoking cessation. Nicotine Tob Res 14: 993-997.
8. Dome P, Lazary J, Kalapos MP, Rihmer Z (2010) Smoking, nicotine and neuropsychiatric disorders. Neurosci Biobehav Rev 34: 295-342.
9. Tsai SJ, Yeh HL, Hong CJ, Liou YJ, Yang AC, et al. (2012) Association of CHRNA4 polymorphism with depression and loneliness in elderly males. Genes Brain Behav 11: 230-234.
10. Markett S, Montag C, Reuter M (2011) The nicotinic acetylcholine receptor gene CHRNA4 is associated with negative emotionality. Emotion 11: 450-455.
11. Perera S, Crewther D, Croft R, Keage H, Hermens D, et al. (2012) Comorbid externalising behaviour in AD/HD: evidence for a distinct pathological entity in adolescence. PLoS One 7: e41407.
12. Sun J, Bi J, Chan G, Oslin D, Farrer L, et al. (2012) Improved methods to identify stable, highly heritable subtypes of opioid use and related behaviors. Addict Behav 37: 1138-1144.
13. Kaneko Y, Masuko H, Sakamoto T, Iijima H, Naito T, et al. (2013) Asthma phenotypes in Japanese adults - their associations with the CCL5 and ADRB2 genotypes. Allergol Int 62: 113-121.
14. Szadoczky E, Papp Z, Vitrai J, Rihmer Z, Furedi J (1998) The prevalence of major depressive and bipolar disorders in Hungary. Results from a national epidemiologic survey. J Affect Disord 50: 153-162.
15. Roe BE, Tilley MR, Gu HH, Beversdorf DQ, Sadee W, et al. (2009) Financial and psychological risk attitudes associated with two single nucleotide polymorphisms in the nicotine receptor (CHRNA4) gene. PLoS One 4: e6704.
16. Winterer G, Musso F, Konrad A, Vucurevic G, Stoeter P, et al. (2007) Association of attentional network function with exon 5 variations of the CHRNA4 gene. Hum Mol Genet 16: 2165-2174. (Pubitemid 47354899)
17. Tapper AR, McKinney SL, Nashmi R, Schwarz J, Deshpande P, et al. (2004) Nicotine activation of alpha4*receptors: sufficient for reward, tolerance, and sensitization. Science 306: 1029-1032. (Pubitemid 39482905)
18. Steinlein OK, Magnusson A, Stoodt J, Bertrand S, Weiland S, et al. (1997) An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Hum Mol Genet 6: 943-947. (Pubitemid 27239081)
19. Ross SA, Wong JY, Clifford JJ, Kinsella A, Massalas JS, et al. (2000) Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse. J Neurosci 20: 6431-6441.
20. Gold AB, Lerman C (2012) Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes. Hum Genet.
21. Pergadia ML, Heath AC, Martin NG, Madden PA (2006) Genetic analyses of DSM-IV nicotine withdrawal in adult twins. Psychol Med 36: 963-972. (Pubitemid 43827368)
22. Saccone SF, Pergadia ML, Loukola A, Broms U, Montgomery GW, et al. (2007) Genetic linkage to chromosome 22q12 for a heavy-smoking quantitative trait in two independent samples. Am J Hum Genet 80: 856-866. (Pubitemid 46668454)
23. Covey LS, Glassman AH, Stetner F (1990) Depression and depressive symptoms in smoking cessation. Compr Psychiatry 31: 350-354. (Pubitemid 20333849)
24. Madden PA, Bucholz KK, Dinwiddie SH, Slutske WS, Bierut LJ, et al. (1997) Nicotine withdrawal in women. Addiction 92: 889-902. (Pubitemid 27326241)
25. Pergadia ML, Agrawal A, Heath AC, Martin NG, Bucholz KK, et al. (2010) Nicotine withdrawal symptoms in adolescent and adult twins. Twin Res Hum Genet 13: 359-369.
26. Glassman AH, Covey LS, Stetner F, Rivelli S (2001) Smoking cessation and the course of major depression: a follow-up study. Lancet 357: 1929-1932. (Pubitemid 32568334)
27. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991) The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86: 1119-1127.
28. Hughes JR, Hatsukami D (1986) Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43: 289-294. (Pubitemid 16052281)
29. Zung WW, Richards CB, Short MJ (1965) Self-rating depression scale in an outpatient clinic. Further validation of the SDS. Arch Gen Psychiatry 13: 508-515.
30. The International HapMap Consortium (2003) The International HapMap Project. Nature 426: 789-796.
31. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265. (Pubitemid 40202029)
32. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, et al. (2002) The structure of haplotype blocks in the human genome. Science 296: 2225-2229. (Pubitemid 34680308)
33. Lazary J, Lazary A, Gonda X, Benko A, Molnar E, et al. (2008) New evidence for the association of the serotonin transporter gene (SLC6A4) haplotypes, threatening life events, and depressive phenotype. Biol Psychiatry 64: 498-504.